Lightning Talk
A Call for Early SLE Intervention in Minoritizied Patients
Exhibit Hall, Booth #3257
Developed and offered by GSK (Non-CME)
Loading view.
Lightning Talk
Q&A/Continue the Conversation
Exhibit Hall, Booth #3257
(Non-CME)
Innovation Theater
Collaborative Frameworks in CAR T-Cell Therapy for Autoimmune Diseases
Exhibit Hall, Innovation Theater A
Developed and offered by Bristol Myers Squibb (Non-CME)
Innovation Theater
Real-World Solutions: The Role of Novel Biomarkers in Diagnosing SLE and RA
Exhibit Hall, Innovation Theater B
Developed and offered by Exagen (Non-CME)
Innovation Theater
Changing the Treatment Paradigm in Recurrent Pericarditis (RP): Moving Beyond an Episodic Approach
Exhibit Hall, Innovation Theater A
Developed and offered by Kiniksa Pharmaceuticals (Non-CME)
Innovation Theater
Expert Perspectives on Dual Inhibition of IL-17A + IL-17F: A Different Mechanism of Action
Exhibit Hall, Innovation Theater B
Developed and offered by UCB (Non-CME)
Industry-Supported Symposium
What We Know About This Oral Medication in Moderate-to-Severe Plaque Psoriasis and Its 4-Year Data
Marriott Marquis, Room Capitol/Congress
Developed and offered by Bristol Myers Squibb (Non-CME)
Industry-Supported Symposium
Does Control of Inflammation Matter? Striving for Better Patient Outcomes in PsA and axSpA
Marriott Marquis, Room Liberty I/J/K/L
Developed and offered by UCB (Non-CME)
Industry-Supported Symposium
Advances in Systemic Lupus Erythematosus (SLE) Management: An Expert Discussion on Treat-to-Target Approaches and a Clinical Data Review of a Novel Treatment Option
Marriott Marquis, Room Independence E/F/G/H
Developed and offered by AstraZeneca (Non-CME)
Industry-Supported Symposium
Unraveling IL-23, the Common Thread Across Psoriasis, Psoriatic Arthritis, and Ulcerative Colitis
Marriott Marquis, Room Catholic University/University of DC
Developed and offered by Johnson & Johnson (Non-CME)
Innovation Theater
Achieving an Immune System RESET: The Next Act in CAR T Therapy
Exhibit Hall, Innovation Theater A
Developed and offered by Cabaletta Bio (Non-CME)
Innovation Theater
Three Rheumatologic Diseases, One FDA-Approved Option to Consider for Appropriate Patients, From Juveniles to Adults
Exhibit Hall, Innovation Theater B
Developed and offered by Sanofi Pharmaceuticals (Non-CME)
Popular Articles
-
ACR/EULAR Develop New APS Classification Criteria
-
ARP Keynote: Lifestyle Medicine Benefits Patients
-
Gluck Memorial Lecture Outlines the Quest for Optimal Fracture Risk Prediction and Bone Strength Measurements
-
Experts Discuss Barriers, Drivers, and Solutions for Health Disparities in Rheumatology
-
Physician-Owners to Offer a Checklist for Opening a Private Practice